{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:48:42Z","timestamp":1787496522317,"version":"build-2736575974"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00411","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T02:15:32Z","timestamp":1588817732000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["Mitragynine Attenuates Morphine Withdrawal Effects in Rats\u2014A Comparison With Methadone and Buprenorphine"],"prefix":"10.3389","volume":"11","author":[{"given":"Rahimah","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheah","family":"Pike See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasidharan","family":"Sreenivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif M.","family":"Mansor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zurina","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"B1","volume-title":"Opioid overdose crisis.","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107972","article-title":"Confronting the opioid crisis with basic research in neuropharmacology","volume":"166","author":"Baumann","year":"2020","journal-title":"Neuropharmacology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.105993","article-title":"Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial","volume":"91","author":"Socias","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl analogs, and U-47700 \u2014 10 States, July\u2013December 2016","volume":"66","author":"O'Donnell","year":"2017","journal-title":"Morbid Mortal Wkly Rep (MMWR)"},{"key":"B5","volume-title":"Illicit drug overdose deaths in BC (January 1 2009\u2013January 31, 2019).","year":"2019"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/add.14878","article-title":"The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States","volume":"115","author":"Hoots","year":"2020","journal-title":"Addiction"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnx015","article-title":"Increase in drug overdose deaths involving fentanyl\u2014Rhode Island, January 2012\u2013March 2014","volume":"19","author":"Mercado","year":"2017","journal-title":"Pain Med"},{"key":"B8","volume-title":"World Drug Report 2019: United Nations publication, Sales No. E.19.XI.8.","year":"2019"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2016.1192642","article-title":"Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response","volume":"48","author":"Dinis-Oliveira","year":"2016","journal-title":"Drug Metab Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.drugalcdep.2011.10.031","article-title":"Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology","volume":"121","author":"Whistler","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"B13","first-page":"S5","article-title":"Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1999.tb127675.x","article-title":"Mortality associated with New South Wales methadone programs in 1994: lives lost and saved","volume":"170","author":"Caplehorn","year":"1999","journal-title":"Med J Aust"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2018.1545131","article-title":"A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine","volume":"45","author":"Kelty","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","article-title":"Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences","volume":"25","author":"M\u00e9garbane","year":"2006","journal-title":"Toxicol Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/hup.698","article-title":"Buprenorphine mortality, seizures and prescription data in the UK, 1980\u20132002","volume":"20","author":"Schifano","year":"2005","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"B19","article-title":"A study of kratom eaters in Thailand","volume":"27","author":"Suwanlert","year":"1975","journal-title":"Bull Narc"},{"key":"B20","article-title":"Psychoactive plant abuse: the identification of mitragynine in ketum and in ketum preparations","volume":"57","author":"Chan","year":"2005","journal-title":"Bull Narc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of kratom use and health impact in the US-Results from an online survey","volume":"176","author":"Grundmann","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1100118","article-title":"The Mitragyna species of Asia \u2013 Part IV. The alkaloids of the leaves of Mitragyna speciosa Korth. isolation of mitragynine and speciofoline","volume":"13","author":"Beckett","year":"1965","journal-title":"Planta Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1001\/jama.2019.6339","article-title":"Kratom-related deaths","volume":"321","author":"Kuehn","year":"2019","journal-title":"JAMA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119862530","article-title":"Characteristics of deaths associated with kratom use","volume":"33","author":"Corkery","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2016.12.020","article-title":"Mitragynine concentrations in two fatalities","volume":"271","author":"Domingo","year":"2017","journal-title":"Forensic Sci Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1811055","article-title":"Deaths in Colorado attributed to kratom","volume":"380","author":"Gershman","year":"2019","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom\u2014Pharmacology, clinical implications, and outlook: a comprehensive review","volume-title":"Pain Ther","author":"Eastlack","year":"2020"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J Am Chem Soc"},{"key":"B30","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck","year":"2012","journal-title":"J Am Osteopath Assoc"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa Korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in \u03b2-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2006.06.007","article-title":"Opioid receptor signaling: relevance for gastrointestinal therapy","volume":"6","author":"Bohn","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jep.2011.04.011","article-title":"Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW264.7 macrophage cells","volume":"136","author":"Utar","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.03.078","article-title":"The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK-N-SH neuroblastoma cell","volume":"148","author":"Jamil","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119844186","article-title":"Mitragynine (Kratom) impairs spatial learning and hippocampal synaptic transmission in rats","volume":"33","author":"Hassan","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jep.2017.12.017","article-title":"Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia","volume":"214","author":"Singh","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2010.03.036","article-title":"Effects of mitragynine from Mitragyna speciosa Korth leaves on working memory","volume":"129","author":"Apryani","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2010.08.011","article-title":"Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression","volume":"18","author":"Farah Idayu","year":"2011","journal-title":"Phytomedicine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules18010666","article-title":"The combination of mitragynine and morphine prevents the development of morphine tolerance in mice","volume":"18","author":"Fakurazi","year":"2013","journal-title":"Molecules"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-3866-5","article-title":"Discriminative stimulus properties of mitragynine (kratom) in rats","volume":"232","author":"Harun","year":"2015","journal-title":"Psychopharmacol (Berl)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2017.05.059","article-title":"Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats","volume":"332","author":"Yusoff","year":"2017","journal-title":"Behav Brain Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/adb.12185","article-title":"Abuse potential and adverse cognitive effects of mitragynine (kratom)","volume":"21","author":"Yusoff","year":"2016","journal-title":"Addict Biol"},{"key":"B44","unstructured":"Evaluation of analgesia induced by mitragynine, morphine and paracetamol on mice. In: ASEAN Review of Biodiversity and Environmental Conservation (ARBEC)17\n            IdidSZ\n            BensaadL\n            YaacobH\n            MustaphaMS\n          1998"},{"key":"B45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ddr.21052","article-title":"Dose-response relationship, acute toxicity, and therapeutic index between the alkaloid extract of Mitragyna speciosa and its main active compound mitragynine in mice","volume":"74","author":"Sabetghadam","year":"2013","journal-title":"Drug Dev Res"},{"key":"B46","volume-title":"Pharmacokinetics and investigation of the anxiolytic-like effects of mitragynine in rats. [Dissertation].","author":"Ganaby","year":"2016"},{"key":"B47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1369-1600.2009.00184.x","article-title":"Mechanisms of respiratory insufficiency induced by methadone overdose in rats","volume":"15","author":"Chevillard","year":"2010","journal-title":"Addict Biol"},{"key":"B48","article-title":"Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone","volume":"230","author":"McCormick","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15691.x","article-title":"Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism","volume":"119","author":"Ruiz","year":"1996","journal-title":"Br J Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)90258-5","article-title":"A comparison of the antinociceptive effects of opioid agonists in neonatal and adult rats in phasic and tonic nociceptive tests","volume":"49","author":"McLaughlin","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"B51","article-title":"Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor","volume":"289","author":"Morgan","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br J Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1258\/la.2012.012058","article-title":"Optimizing the dosing interval of buprenorphine in a multimodal postoperative analgesic strategy in the rat: minimizing side-effects without affecting weight gain and food intake","volume":"46","author":"Schaap","year":"2012","journal-title":"Lab Anim"},{"key":"B54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6882-2-6","article-title":"Experimental study of the morphine de-addiction properties of Delphinium denudatum Wall","volume":"2","author":"Rahman","year":"2002","journal-title":"BMC Complement Altern Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/bf00428791","article-title":"Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats","volume":"33","author":"Bl\u00e4sig","year":"1973","journal-title":"Psychopharmacologia"},{"key":"B56","article-title":"Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine","volume":"236","author":"Neal","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.02.008","article-title":"Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats","volume":"146","author":"Sabetghadam","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"B58","first-page":"25","article-title":"Multiple comparisons of independent means","volume-title":"Applied analysis of variance in behavioral science.","author":"Ramsey","year":"1993"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(92)90051-p","article-title":"Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists","volume":"31","author":"Maldonado","year":"1992","journal-title":"Neuropharmacology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189837","article-title":"Sex-specific reference intervals of hematologic and biochemical analytes in Sprague-Dawley rats using the nonparametric rank percentile method","volume":"12","author":"He","year":"2017","journal-title":"PloS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.etp.2005.10.002","article-title":"Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies","volume":"57","author":"Petterino","year":"2006","journal-title":"Exp Toxicol Pathol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21776\/ub.jpacr.2017.006.03.355","article-title":"Green tea extract (Camellia sinensis L.) effects on uric acid levels on hyperuricemia rats (Rattus norvegicus)","volume":"6","author":"Nugraheni","year":"2017","journal-title":"J Pure App Chem Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/vcp.12419","article-title":"Reference intervals for biochemical blood variables, packed cell volume, and body temperature in pet rats (Rattus norvegicus) using point-of-care testing","volume":"45","author":"Houtmeyers","year":"2016","journal-title":"Vet Clin Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12385","article-title":"Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice","volume":"22","author":"Ismail","year":"2017","journal-title":"Addict Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1511879","article-title":"Severity of kratom (Mitragyna speciosa Korth.) psychological withdrawal symptoms","volume":"50","author":"Singh","year":"2018","journal-title":"J Psychoactive Drugs"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2015.1012610","article-title":"Social functioning of kratom (Mitragyna speciosa) users in Malaysia","volume":"47","author":"Singh","year":"2015","journal-title":"J Psychoactive Drugs"},{"key":"B68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/02791072.2018.1555345","article-title":"Long-term cognitive effects of kratom (Mitragyna speciosa Korth.) use","volume":"51","author":"Singh","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"B69","first-page":"398","article-title":"Quantitative aspects of precipitated abstinence in morphine-dependent rats","volume":"184","author":"Wei","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"B70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/bf00413955","article-title":"Assessment of precipitated abstinence in morphine-dependent rats","volume":"28","author":"Wei","year":"1973","journal-title":"Psychopharmacologia"},{"key":"B71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0014-2999(94)90755-2","article-title":"Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat","volume":"253","author":"Gold","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/bf00422405","article-title":"Acute physical dependence induced by continuous intravenous infusion of morphine or meperidine in the rat","volume":"73","author":"Nakaki","year":"1981","journal-title":"Psychopharmacol (Berl)"},{"key":"B73","first-page":"40","article-title":"Withdrawal characteristics following frequent intravenous administration of several opioids in rats","volume":"29","author":"Wakasa","year":"1994","journal-title":"Arukoru Kenkyuto Yakubutsu Ison"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01434-9","article-title":"Characterization of neonatal rat morphine tolerance and dependence","volume":"340","author":"Thornton","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192340","article-title":"Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels","volume":"13","author":"Schaefer","year":"2018","journal-title":"PloS One"},{"key":"B76","article-title":"Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions","volume":"205","author":"Gellert","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(86)90077-8","article-title":"Production of physical dependence in rats by drinking a morphine solution","volume":"25","author":"Leung","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/290414","article-title":"Effect of chronic morphine consumption on synaptic plasticity of rat's hippocampus: A transmission electron microscopy study","volume":"2013","author":"Heidari","year":"2013","journal-title":"Neurol Res Int"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.25.453","article-title":"Physical dependence on morphine, phenobarbital and diazepam in rats by drug-admixed food ingestion","volume":"25","author":"Yanaura","year":"1975","journal-title":"Jpn J Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/bf02245230","article-title":"Effects of morphine and naloxone on behaviour in the hot plate test: an ethopharmacological study in the rat","volume":"113","author":"Espejo","year":"1994","journal-title":"Psychopharmacol (Berl)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.npp.1300315","article-title":"Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats","volume":"29","author":"Raghavendra","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"B82","article-title":"Attenuation of morphine physical dependence and blood levels of cortisol by central and systemic administration of ramelteon in rat","volume":"40","author":"Motaghinejad","year":"2015","journal-title":"Iran J Med Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/fbp.0000000000000197","article-title":"Effect of environmental enrichment on physical and psychological dependence signs and voluntary morphine consumption in morphine-dependent and morphine-withdrawn rats","volume":"27","author":"Hammami-Abrand Abadi","year":"2016","journal-title":"Behav Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/bf00408180","article-title":"Tolerance to and physical dependence on morphine in rats","volume":"4","author":"Martin","year":"1963","journal-title":"Psychopharmacologia"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3329\/bjms.v15i2.27550","article-title":"An experimental study of ethanolic extract and methanolic fraction of Delphinium denudatum Wall in morphine withdrawal syndrome","volume":"2","author":"Zaheer","year":"2016","journal-title":"J Med Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00141.x","article-title":"The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine","volume":"49","author":"Stuart-Harris","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"B87","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"B88","first-page":"794","article-title":"Subcutaneous compared with intraperitoneal ketamine-xylazine for anesthesia of mice","volume":"55","author":"Levin-Arama","year":"2016","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Review article: Effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment","volume":"28","author":"Kosten","year":"2019","journal-title":"Am J Addict"},{"key":"B90","article-title":"First-pass effect of morphine in rats","volume":"200","author":"Iwamoto","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/16.9.535","article-title":"Pharmacokinetics 101","volume":"16","author":"Ito","year":"2011","journal-title":"Paediatr Child Health"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.08.021","article-title":"Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine","volume":"69","author":"Goeldner","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B93","first-page":"1480","volume-title":"A dictionary of the economic products of the Malay Peninsula.","author":"Burkill","year":"1935"},{"key":"B94","article-title":"Mitragynine reduced morphine-induced conditioned place preference and withdrawal in rodents","volume":"43","author":"Meepong","year":"2019","journal-title":"Thai J Pharm Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/s0024-3205(98)00075-7","article-title":"Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice","volume":"62","author":"Thongpradichote","year":"1998","journal-title":"Life Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbr.2018.02.039","article-title":"Baclofen blocks the acquisition and expression of mitragynine-induced conditioned place preference in rats","volume":"345","author":"Yusoff","year":"2018","journal-title":"Behav Brain Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028340","article-title":"Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish","volume":"6","author":"Khor","year":"2011","journal-title":"PloS One"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA"},{"key":"B100","article-title":"The absorption, distribution and excretion of D,L-methadone","volume":"97","author":"Way","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"B101","article-title":"Studies on the distribution and metabolism of methadone in normal and tolerant rats by a new colorimetric method","volume":"98","author":"Rickards","year":"1950","journal-title":"J Pharmacol Exp Ther"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1981.tb10473.x","article-title":"In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions","volume":"74","author":"Dum","year":"1981","journal-title":"Br J Pharmacol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/bf02246290","article-title":"Effects of buprenorphine and methadone in methadone-maintained subjects","volume":"119","author":"Walsh","year":"1995","journal-title":"Psychopharmacol (Berl)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction","volume":"30","author":"Veilleux","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnr.2005.08.012","article-title":"Recent advances in the treatment of opiate addiction","volume":"5","author":"Ling","year":"2005","journal-title":"Clin Neurosci Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(02)00009-X","article-title":"Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine","volume":"15","author":"Gopal","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/bf02703705","article-title":"Liver and kidney toxicity in chronic use of opioids: an experimental long term treatment model","volume":"30","author":"Atici","year":"2005","journal-title":"J Biosci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1160\/th03-05-0276","article-title":"Effects of biological variations on platelet count in healthy subjects in China","volume":"91","author":"Peng","year":"2004","journal-title":"Thromb Haemost"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2003.11.005","article-title":"Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity","volume":"49","author":"Pari","year":"2004","journal-title":"Pharmacol Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12456","article-title":"Methadone complications amongst opioid-dependent patients in Malaysia: a case series","volume":"37","author":"George","year":"2018","journal-title":"Drug Alcohol Rev"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms130911427","article-title":"Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system","volume":"13","author":"Shamima","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.fitote.2015.12.001","article-title":"Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats","volume":"109","author":"Carpenter","year":"2016","journal-title":"Fitoterapia"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05247-7","article-title":"The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats","volume":"236","author":"Hiranita","year":"2019","journal-title":"Psychopharmacol (Berl)"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12639","article-title":"Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine","volume":"24","author":"Hemby","year":"2019","journal-title":"Addict Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.06.028","article-title":"Animal models of psychoactive drug use and addiction \u2013 present problems and future needs for translational approaches","volume":"352","author":"M\u00fcller","year":"2018","journal-title":"Behav Brain Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00411\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T02:15:44Z","timestamp":1588817744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00411\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":115,"alternative-id":["10.3389\/fpsyt.2020.00411"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00411","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"article-number":"411"}}